Clin Exp Reprod Med > Volume 50(2); 2023 > Article |
|
Characteristic | Participants (n=147) |
---|---|
Age (yr) | 26.27±5.67 |
Parity | 0.19±0.45 |
Height (cm) | 162.34±5.45 |
Body weight (kg) | 58.82±14.85 |
Body mass index (kg/m2) | 22.27±5.30 |
Waist-to-hip ratio | 0.80±0.07 |
Total follicle count | 65.77±33.34 |
Total ovarian volume (cm3) | 22.66±9.77 |
Fasting insulin (μIU/mL) | 6.85 (1.70–134.50) |
Fasting glucose (mg/dL) | 92.24±14.98 |
INS2 (μIU/mL)a) | 51.85 (11.30–208.10) |
PG2 (mg/dL) | 112.20±42.44 |
HOMA-IR (fasting) | 1.51 (0.33–36.63) |
GIR (fasting) | 15.77±10.90 |
QUICKI (fasting) | 0.36±0.05 |
Cholesterol (mg/dL) | 175.55±30.37 |
Triglyceride (mg/dL) | 93.60±81.86 |
HDL (mg/dL) | 59.97±14.95 |
LDL (mg/dL) | 95.95±26.59 |
Values are presented as mean±standard deviation or median (range).
INS2, postprandial insulin at 2 hours; PG2, postprandial glucose at 2 hours; HOMA-IR, homeostasis model assessment of insulin resistance; GIR, glucose-to-insulin ratio; QUICKI, quantitative insulin sensitivity check index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Variable |
Total follicle count |
Total ovarian volume (cm3) |
||||||
---|---|---|---|---|---|---|---|---|
r | p-value | ra) | p-value | r | p-value | ra) | p-value | |
Fasting insulin (μIU/mL) | 0.203 | 0.016b) | 0.216 | 0.020b) | 0.099 | 0.243 | 0.137 | 0.143 |
Fasting glucose (mg/dL) | 0.080 | 0.348 | 0.054 | 0.568 | 0.019 | 0.823 | 0.040 | 0.673 |
INS2 (μIU/mL)c) | 0.071 | 0.592 | −0.022 | 0.873 | 0.119 | 0.366 | 0.041 | 0.761 |
PG2 (mg/dL) | 0.120 | 0.160 | 0.060 | 0.525 | 0.031 | 0.721 | 0.079 | 0.404 |
HOMA-IR (fasting) | 0.213 | 0.011b) | 0.193 | 0.038b) | 0.098 | 0.250 | 0.134 | 0.153 |
GIR (fasting) | −0.193 | 0.022b) | −0.259 | 0.005b) | −0.105 | 0.216 | −0.120 | 0.201 |
QUICKI (fasting) | −0.213 | 0.011b) | −0.266 | 0.004b) | −0.098 | 0.246 | −0.143 | 0.126 |
Cholesterol (mg/dL) | 0.129 | 0.138 | 0.128 | 0.177 | 0.004 | 0.963 | 0.062 | 0.517 |
Triglyceride (mg/dL) | 0.055 | 0.533 | −0.075 | 0.431 | −0.020 | 0.824 | −0.051 | 0.589 |
HDL (mg/dL) | −0.053 | 0.548 | 0.135 | 0.153 | 0.093 | 0.291 | 0.066 | 0.484 |
LDL (mg/dL) | 0.182 | 0.038b) | 0.190 | 0.045b) | 0.014 | 0.874 | 0.071 | 0.456 |
r, Spearman rank correlation coefficient; INS2, postprandial insulin at 2 hours; PG2, postprandial glucose at 2 hours; HOMA-IR, homeostasis model assessment of insulin resistance; GIR, glucose-to-insulin ratio; QUICKI, quantitative insulin sensitivity check index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
Variable | Group 1 (n=74)a) | Group 2 (n=73)b) | p-value |
---|---|---|---|
Fasting insulin (μIU/mL) | 6.10 (1.70–42.50) | 7.90 (1.90–134.50) | 0.022c) |
Fasting glucose (mg/dL) | 90.49±10.66 | 94.00±18.27 | 0.166 |
INS2 (μIU/mL)d) | 44.50 (15.10–142.60) | 56.40 (11.30–208.10) | 0.483e) |
PG2 (mg/dL) | 107.52±37.54 | 117.00±46.90 | 0.192 |
HOMA-IR (fasting) | 1.33 (0.33–30.55) | 1.73 (0.42–36.63) | 0.025c) |
GIR (fasting) | 17.20±10.90 | 14.29±10.83 | 0.114 |
QUICKI (fasting) | 0.37±0.04 | 0.35±0.05 | 0.033c) |
Cholesterol (mg/dL) | 173.11±32.62 | 182.12±27.70 | 0.088 |
Triglyceride (mg/dL) | 93.43±78.66 | 94.21±85.96 | 0.957 |
HDL (mg/dL) | 59.12±15.25 | 60.73±14.82 | 0.540 |
LDL (mg/dL) | 94.71±25.88 | 103.54±26.80 | 0.058 |
Values are presented as mean±standard deviation or median (range). p-values are unpaired t-test.
INS2, postprandial insulin at 2 hours; PG2, postprandial glucose at 2 hours; HOMA-IR, homeostasis model assessment of insulin resistance; GIR, glucose to insulin ratio; QUICKI, quantitative insulin sensitivity check index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.